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Influenza poses a continuing public health threat in
epidemic and pandemic seasons. The 1951 influenza epi-
demic (A/H1N1) caused an unusually high death toll in
England; in particular, weekly deaths in Liverpool even sur-
passed those of the 1918 pandemic. We further quantified
the death rate of the 1951 epidemic in 3 countries. In
England and Canada, we found that excess death rates
from pneumonia and influenza and all causes were sub-
stantially higher for the 1951 epidemic than for the 1957
and 1968 pandemics (by >50%). The age-specific pattern
of deaths in 1951 was consistent with that of other interpan-
demic seasons; no age shift to younger age groups, remi-
niscent of  pandemics, occurred in the death rate. In
contrast to England and Canada, the 1951 epidemic was
not particularly severe in the United States. Why this epi-
demic was so severe in some areas but not others remains
unknown and highlights major gaps in our understanding of
interpandemic influenza.
I
nfluenza is responsible for large increases in deaths in
pandemic seasons when emerging viral subtypes with
novel surface antigens become predominant, and also in
some interpandemic seasons, when established subtypes
exhibit antigenic drift (1). The circulating viral subtype is
associated with varying severity of influenza epidemics
(2): in the last 2 decades in the United States, estimated
excess death rates were on average 2.8-fold higher in
A/H3N2-dominated seasons than in A/H1N1 and B sea-
sons (3). Within a given subtype, however, the strain-spe-
cific determinants of epidemic severity are still poorly
understood. For instance in the United States in the same
period, excess death rates varied nearly 4-fold among
A/H3N2 seasons, even after adjustments for population
aging (3). Better characterizations of past severe influenza
epidemics can help understand and perhaps help predict
the occurrence of severe epidemics. 
Anecdotal accounts exist in the literature of historical
influenza epidemics associated with unusual numbers of
deaths, such as occurred in the 1951 epidemic in England
in the midst of the first era of A/H1N1 viruses
(1918–1957) (4). In Liverpool, where the epidemic was
said to originate, it was “the cause of the highest weekly
death toll, apart from aerial bombardment, in the city’s
vital statistics records, since the great cholera epidemic of
1849” (5). This weekly death toll even surpassed that of
the 1918 influenza pandemic (Figure 1).
The international pattern of influenza-related deaths in
1951 has not been adequately quantified in the past
because of lack of methodologic tools and historical death
records. However, this historical epidemic is a good exam-
ple to illustrate major gaps in our current understanding of
influenza virus epidemiology. We revisited the 1951 epi-
demic by quantifying its death rate  in 3 countries (England
and Wales, Canada, the United States) and comparing its
age-specific mortality pattern with that of surrounding epi-
demic and pandemic seasons (1).
Methods 
Data
We obtained monthly pneumonia and influenza (P&I)
and all-cause numbers of deaths for 1950 to 1999 from
Health Canada (6), by 5-year age groups (details on the
International Classification of Diseases codes used are
given in Table 1). Canada was the only country with
detailed age-specific mortality data for the 1950s readily
available in electronic format. 
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simplicity), we compiled P&I and all-cause deaths by
month for 1950 to 1999 from the Registrar General
(1950–1958, [7]), and National Statistics (1959–1999, [8]).
In both countries, monthly deaths were normalized by pop-
ulation size to obtain comparable death rates over time and
these were standardized to 30.5-day months (Figure 2).
Population data were obtained from the same agencies
(6,8).
As US monthly vital statistics were not available elec-
tronically since 1950, we compiled excess death estimates
from various historical publications (9–12). These esti-
mates were based on National Vital Statistics and death
records from P&I and all causes in major American cities
compiled by the Centers for Disease Control and
Prevention and derived from excess mortality models sim-
ilar to ours (see below). 
We also conducted a literature search to compile reports
describing the local patterns and geographic spread of the
1951 influenza epidemic in the 3 countries (5,9,13,14).
Moreover, we obtained mortality data specifically for
Liverpool, where the 1951 epidemic had the highest
impact and death records have been previously described
(5,13,15,16) (Figure 1).
Seasonal Excess Death Rate Estimates, 
Canada and England
Our primary goal in this study was to compare the death
rate of the 1951 epidemic with that of the 1957 and 1968
pandemics. For this purpose, we fit a seasonal model to
P&I and all-cause deaths for 1950 to 1971, capturing all 3
influenza seasons of interest, as described below. We pres-
ent monthly time series and seasonal estimates for this
period (20 seasons, see Figure 2 for P&I). A secondary
goal was to compare the age mortality pattern of the 1951
epidemic with that of other influenza seasons. To have
more statistical power and analyze several influenza sea-
sons with substantial death rates, we also used an extend-
ed study period, 1950–1999. 
For Canada and England, we applied a modified ver-
sion of Serfling’s classical seasonal regression model to
monthly data on death rates for each country (17), as
described elsewhere (3,18). We obtained a baseline for
deaths in the absence of influenza, separately for each out-
come (P&I and all-cause) and available age group (see
Figure 2 for P&I). Seasonal excess deaths were then esti-
mated as the number of deaths in excess of the baseline
during months of increased influenza activity. 
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Figure 1. Comparison of 1951 epidemic (A/H1N1) with the 1918 and 1957 pandemics (A/H1N1 and A/H2N2, respectively) in Liverpool,
England. Time series of weekly death rates from A) respiratory causes (pneumonia, influenza and bronchitis) and B) all causes.
Epidemics were aligned at the week of peak mortality (peak week = week ended Feb 22, 1919; Jan 13, 1951; Oct 12, 1957). The 1918
pandemic occurred in 3 waves in Liverpool (summer 1918, autumn 1918, winter 1919); the “third wave” was associated with the highest
death rate and is represented here. 
ABStandardization of Seasonal Excess Death Rates
Since our goal was to compare influenza deaths across
multiple seasons and countries, we had to control for base-
line differences in demography, healthcare, and socioeco-
nomic status that may affect influenza-related deaths. To
this end, we calculated age-adjusted seasonal excess death
estimates in a manner previously described (3,18). Further,
to control for residual differences in baseline death rates
related to health and socioeconomic status, we adjusted the
seasonal estimates for temporal changes in mortality in the
summer months, when influenza is absent (18). We used
year 1960, midpoint of the main study period 1950–1971,
as an index.  
Age-Specific Patterns of Seasonal Excess Death
Rates, Canada
We examined whether the 1951 epidemic had an epi-
demic or pandemic mortality age pattern, as indicated by a
shift in the age distribution of deaths towards younger age
groups (1). In Canada, the 1950–51 season was the first
season in our mortality records with complete age details.
Hence, we could not evaluate a potential age shift between
earlier seasons and the 1950–51 season, as described else-
where (1). 
We therefore developed an alternative method to iden-
tify a pandemic signature, in which we compared the grad-
ual increase of influenza-related deaths with age between
epidemic and pandemic seasons. We first used all moder-
ate-to-severe influenza seasons in the interpandemic peri-
ods to obtain a null distribution of mortality age patterns
during epidemics (we chose the 17 seasons above the
median). Second, we checked that we could actually detect
a pandemic age pattern by comparing the null epidemic
pattern with those of the 1957 and 1968 pandemics. Then,
we compared the null pattern with that of the 1951 epidem-
ic. To model the gradual increase of influenza-related
deaths with age in adults, we fitted an exponential to unad-
justed P&I excess death rates by 5-year age groups for per-
sons >55 years of age. The test then relied on comparing
between seasons the values of the age and intercept coeffi-
cients of the exponential models. Bootstrap resampling of
influenza seasons in the interpandemic periods yielded a p
value for the test.
Results 
Geographic and Temporal Spread
Influenza activity started to increase in Liverpool,
England, in late December 1950 (5,13). The weekly death
rate reached a peak in mid-January 1951 that was ≈40%
higher than the peak of the 1918–19 pandemic, reflecting
a rapid and unprecedented increase in deaths, which lasted
for ≈5 weeks ([5] and Figure 1). Since the early 20th cen-
tury, the geographic spread of influenza could be followed
across England from the weekly influenza mortality statis-
tics in the country’s largest cities, which represented half
of the British population (13). During January 1951, the
epidemic spread within 2 to 3 weeks from Liverpool
throughout the rest of the country. 
For Canada, the first report of influenza illness came
the third week of January from Grand Falls,
Newfoundland (19). Within a week, the epidemic had
reached the eastern provinces, and influenza subsequently
spread rapidly westward (19). 
For the United States, substantial increases in influenza
illness and excess deaths were reported in New England
from February to April 1951, at a level unprecedented
since the severe 1943–44 influenza season. Much milder
epidemics occurred later in the spring elsewhere in the
country (9). 
Local disparities were found in all 3 countries, with a
consistent pattern of higher numbers of deaths in locations
affected earlier (9,13,14). In England, influenza-related
death rates were ≈3-fold higher in Liverpool than in the
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Figure 2. Time series of monthly mortality
from pneumonia and influenza (P&I, rep-
resented as death rate/100,000) from
1950 to 1972 in A) Canada and B)
England and Wales. Black line: observed
deaths, Red line: baseline deaths predict-
ed by a seasonal regression model. Note
the 2 arrows for the 1968 pandemic in
England, representing the 2 waves of the
smoldering A/H3N2 pandemic (1968–69
and 1969–70, respectively) (18).rest of the country (13). In Canada, death rates were ≈2.4-
fold higher in the eastern seaboard provinces than in the
rest of the country (14). Similarly, in the United States,
rates were ≈2.3-fold higher in New England than in the rest
of the country (9). 
Patterns of Seasonal Excess Death Rates, 
All Ages, 3 Countries
Crude and adjusted seasonal excess death estimates in
the 3 countries are presented for the period 1950–1971 in
Figure 3 (P&I). Aspecific comparison of the 1951 epidem-
ic and 1957 pandemic is provided in Table 2 (P&I and all-
cause).
For Canada, the 1951 epidemic was the most severe
influenza season in the period 1950–1999, as indicated by
crude seasonal excess death rates from P&I and all causes
(data not shown). On the basis of both outcomes, the 1951
epidemic caused a 1.5-fold higher death rate than the 1957
pandemic; the rate was 3- to 4-fold higher than that seen in
the 1968 pandemic. Adjusting for factors unrelated to
influenza, such as demographics, health, and socioeco-
nomic status only marginally modified our estimates (by
<11%).
In England, the 1951 epidemic had similar death pat-
terns. It was responsible for the largest increase in winter
deaths from P&I and all causes in the period 1950–1999
(data not shown), with 1.3- to 1.4-fold higher crude excess
death rates than those seen in the 1957 and 1968 pan-
demics. In contrast to Canada, adjusting for trends in demo-
graphics and health care substantially changed our excess
death estimates, exacerbating the impact of the 1951 epi-
demic. Baseline P&I summer death rates doubled from
1950 to 1970 (Figure 2), probably because of rapid aging of
the British population. During these 2 decades, the propor-
tion of persons >65 years of age increased by 2.3% in
England, which explains the trend in British death rates; in
comparison, it increased by only 0.3% in Canada (6,8).
In the United States, by contrast, the 1951 epidemic
was not particularly severe, except possibly in the New
England region, adjacent to Canada. In the United States,
this epidemic ranked with low-to-moderate influenza sea-
sons, with only half the impact of the 1957 pandemic for
P&I deaths and even less for all-cause deaths. 
Estimation of crude and adjusted excess deaths sug-
gests that the 1951 epidemic was unusually severe in
England and Canada but not in the United States. The
absolute rates of excess deaths were very different between
countries, with systematically higher rates in England (by
3- to 5-fold, Table 2). The difference remained even after
adjusting for international differences in demographics and
healthcare and was also found for deaths from all causes,
which controls for potential differences in the coding of
death certificates (Table 2). Such international discrepan-
cies in influenza-related death rates have been highlighted
on several occasions in the past, although not elucidated
(18,20–22). Because of these unresolved differences, this
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Figure 3. Seasonal pneumonia and
influenza (P&I) excess death rates,
all ages, 1950–51 to 1970–71.
Crude death rates (blue bars),
death rates adjusted for summer
trends in mortality unrelated to
influenza (pink bars) and adjusted
for demographics (green bars). A)
Canada. B) England and Wales. C)
USA. Note that for England, com-
parisons used the second A/H3N2
pandemic wave of major impact
(18). Note the 2 arrows for the 1968
pandemic in England, representing
the 2 A/H3N2 pandemic waves
(1968–69 and 1969–70, respec-
tively); the second wave of major
impact was used in comparisons
(18). analysis focused on the relative impact of the 1951 epi-
demic as compared with surrounding influenza seasons.  
Age-specific Patterns of Seasonal Excess 
Death Rates, Canada
Given the unusual death rate of the 1951 influenza epi-
demic in England and Canada, we hypothesized that an
emerging virus subtype may have circulated there, perhaps
with pandemic potential. We investigated the age-specific
mortality pattern of the 1951 epidemic in Canada in rela-
tion to other seasons to address this aspect.
Inspection of P&I excess death rates by age shows that
the 1951 epidemic had the typical pattern of death rates
found in other epidemics, steeply increasing with age after
infancy (Figure 4). Statistical analysis showed that the age
pattern in 1951 was well within the range of the null distri-
bution of reference epidemic seasons in influenza inter-
pandemic periods (Table 3). Conversely, we found lower
age coefficients for the 1957 and 1968 pandemics as com-
pared with reference epidemic seasons, illustrating that
deaths increased less with age in pandemics than in epi-
demics and that our statistical approach could detect a pan-
demic signature (p<0.001) (1).
Discussion
We have shown that the 1951 influenza epidemic had
greater death rate than all subsequent influenza epidemics
or pandemics in England and Canada. In Canada, where
age-detailed data were available, deaths in persons <65
years of age attributable to the 1951 epidemic were nearly
equivalent to those of the 1957 pandemic. But what sets
the 1951 epidemic apart from pandemics is that the older
population was also severely affected, with twice the
deaths as occurred in the 1957 pandemic. By contrast, the
1951 epidemic had minor impact in the United States,
except possibly in New England.
To study influenza death patterns, we used P&I deaths,
a reliable proxy for the timing and relative impact of
influenza epidemics, as well as all-cause deaths, an indica-
tor of their overall impact (23). Cardiovascular deaths are
also widely used to quantify the impact of influenza
(24,25); however, they were not available to us for this
study. But since winter increases in P&I, cardiovascular,
and all-cause deaths are synchronized and correlated in
amplitude during influenza epidemics (25), we capture
here the timing and death rate of these epidemics. 
Influenza-related death rates reflect the combination of
2 underlying epidemiologic parameters: the attack rate, a
measure of a pathogen’s transmissibility, and the case-
fatality rate, a measure of a pathogen’s virulence. The
unusual severity of the 1951 epidemic in England and
Canada may stem from higher attack rates, higher case-
fatality rates, or both. To isolate these factors, we exam-
ined Liverpool, England, where comparable data on illness
and death exist for the 1951 and 1957 pandemics (5). In
Liverpool, influenza attack rates in schoolchildren were 3-
fold lower in 1951 than in 1957, which suggests lower
transmissibility in this age group in 1951. By contrast, an
equal number of influenza-related deaths occurred in the 2
seasons in children in Liverpool, which suggests a higher
case-fatality rate in 1951 than in 1957. Similar findings
were observed in the working adult population (5), an indi-
cation of unusual virulence in the influenza virus circulat-
ing in 1951 in Liverpool. This argument must be taken
with caution, however, since most influenza-related deaths
occur in the elderly (3), and attack rates are not available
for this age group. Estimation of the transmissibility of the
1951 virus using a mathematical model for influenza
1951 Influenza Epidemic
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question, not only in Liverpool but also in the rest of
England and Canada.
Laboratory surveillance data from the World Health
Organization (WHO) indicate that influenza A viruses cir-
culating at the time were characterized as H1N1 (27), a
subtype circulating since the 1918 pandemic (28).
Although an unusually large drift event in the hemagglu-
tinin of A/H1N1 viruses was reported in 1947 (29), subse-
quent changes in this protein remained minor until after
1951 (27). Hence, no virologic evidence of a shift or
unusual drift in the hemagglutinin antigen exists for 1951
viruses. In support of the virologic evidence, we have
shown that no epidemiologic pandemic signature occurred
in 1951, as indicated by an age shift of deaths towards
younger age groups (1). 
The 1951 epidemic exhibited geographic disparities in
influenza-related deaths, as illustrated by the contrast
between England and Canada (countries with high death
rate) and the United States (low death rate). These dispar-
ities are in part explained by laboratory surveillance
reports by WHO (27,30), indicating that 2 antigenically
distinct influenza A/H1N1 strains cocirculated in the
Northern Hemisphere during the 1951 epidemic (27,30).
The so-called “Scandinavian strain” was isolated in north-
ern Europe and associated with mild illnesses. By contrast,
the “Liverpool strain” was associated with severe illnesses
and high deaths in Great Britain, Canada, southern Europe,
and Mediterranean countries (27). As both strains cocircu-
lated in some countries (27), intrasubtypic cross-immunity
might have existed, with these 2 strains competing for sus-
ceptible hosts. 
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Figure 4. Age-specific pneumonia and influenza (P&I)
death rates in the 1951 influenza epidemic, 1957, and
1968 pandemics, Canada.  A) Observed. B) Exponential
models using 5-year age groups starting at age 55 years
and ending at >90 years (R2 >0.85 for all seasons).
Black curve: “null distribution” of expected pattern in epi-
demic seasons, based on major epidemics in the inter-
pandemic periods, 1950–1999 (N = 17). The age
coefficient was set at the mean of the “null” distribution
(see Table 3 for values). The intercept was set at the
minimum of the distribution for legibility. The precise reasons for the unusually high death rate
associated with the Liverpool strain remain elusive. The
genetic markers of influenza virulence are still unclear
today, but a multibasic cleavage site in the hemagglutinin,
as well as minor changes in internal genes, are believed to
enhance viral pathogenicity (31,32). Only hemagglutinin
inhibition tests could be performed in 1951, and to our
knowledge, no influenza virus isolate or genetic sequence
from 1951 is available in the public domain. Further
molecular analysis of 1951 influenza specimens could help
explain the extreme local pathogenicity in that season.
We have described an influenza season that was unex-
pectedly severe in some countries and mild in others. This
geographic disparity in influenza-related deaths is not com-
mon; influenza mortality is generally correlated between
the United States and Europe and within the United States
(33,34). Occasional disparities have been reported, howev-
er. For instance, the impact of the 2 waves of the 1968 pan-
demic differed markedly between North American and
Eurasian countries, perhaps because of differences in pre-
existing immunity and evolving viruses (3,18). In this con-
text, the 1951 epidemic appears as another striking example
of geographic disparities in influenza impact, perhaps
explained in this case by cocirculation of 2 influenza
A/H1N1 strains. Other competing hypotheses include dif-
ferences in preexisting population immunity or socioeco-
nomic factors, but these are less parsimonious explanations.
Many countries are actively preparing for the next
influenza pandemic (35–37). Previous pandemics in the
20th century have been responsible for large numbers of
deaths in all age groups (1); however, the age pattern of
deaths in the 1918 and 1968 pandemics suggest that the
elderly may actually be relatively protected against an
emerging pandemic virus (35,38,39). By contrast, we have
shown that the 1951 epidemic was not associated with the
emergence of a new influenza subtype, yet had a higher
death rate than 2 of the 3 pandemics of the past century in
England and Canada, especially among the elderly, and
higher death rate than all 3 pandemics in Liverpool. We
conclude that pandemics are not always more severe in
terms of deaths than epidemics, for reasons still unclear. A
thorough investigation of the full genome of the influenza
viruses involved in the unusually severe 1951 epidemic
could shed light on the virulence and transmissibility fac-
tors at play and fill key gaps in our current understanding
of interpandemic influenza (40).
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